Known as the cream of the crop in the steroid market,
Methandienone was introduces back in the 1960 and was all the rage among the
bodybuilding
set for the next twenty to thirty years. With the drug widely
available in bodybuilding circles, one would be hard pressed to find a
professional bodybuilder from that era who did not give the little blue
pill a try.
It is interesting to note, however, that
the popularity of the substance may have likely caused its demise.
With word of steroid abuse running rampant in the late 80s and early
90s and horror stories of their ill effects, the Food and Drug
Administration banned the sale and use of the drug and others like it
and declared it an illegal substance.
Known for its ability to produce
immense muscle mass in an extremely short period of time,
GP Methan 50 (Dianabol), has been shown to increase muscle production by up to 20 pounds over a typical two month cycle. In addition,
GP Methan 50 (Dianabol)
increases protein amalgamation, allows users to renew glycogen stores
at a faster rate and increases strength in a very brief period.
Furthermore, the drug, which works almost immediately, is a
complimentary addition to injectable substances that require a longer
timeframe to show effects.
While
GP Methan 50 (Dianabol)
is very effective for athletes in strength related sports such as
weight lifting and bodybuilding, it is not suggested for athletes who
require a large aerobic capacity. The drug has been shown to cause a
dramatic reduction in cell respiration. Other side negative effects,
which normally occur in users taking high levels of the drug (30 to 40
mg / day), include acne, male pattern baldness and extreme anger. In
addition, because of the potential for liver toxicity, failure and even
cancer, it is recommended that users abide by the dosing of no more
than two month cycles.
The drug does not have the high
androgenic component that is found in other steroids, when taken in the
normal usage range it does not create the extreme hormonal
side effects such as male
breast development. In addition, users do not have to be as concerned
about an unwanted shutdown of normal hormone manufacture.